Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiaohan Xu

Showing results (231-240 of 253) with videos related to

Pageof 26
Sort By:
BMJ Open|August 13, 2025
Patient journey and Quality of Life for Patients with Idiopathic Pulmonary Fibrosis (IPFLife) in China: a sequential exploratory mixed methods research protocolHongling Chu, Yanling Ding, Yunxian Zhou, et al.
Nature Communications|March 28, 2023
Mitochondrial ATP synthase as a direct molecular target of chromium(III) to ameliorate hyperglycaemia stressHaibo Wang, Ligang Hu, Hongyan Li, et al.
BMJ Open Respiratory Research|June 24, 2026
Patient experiences of idiopathic pulmonary fibrosis (IPF) in China: a multicentre qualitative studyBixuan Yan, Ning Liu, Yunxian Zhou, et al.
International Journal of Biological Macromolecules|August 12, 2024
A β-1,3/1,6-glucan enhances anti-tumor effects of PD1 antibody by reprogramming tumor microenvironmentQiaoling Song, Yuting Xu, Minghui Zhang, et al.
Acta Biochimica Et Biophysica Sinica|April 25, 2026
Scaffold compound T4015 attenuates pulmonary fibrosis via suppressing JAK/STAT and NF-κB signalingMinghui Zhang, Hang Xu, Shan Liu, et al.
Chemical Science|April 13, 2022
Multiplex metal-detection based assay (MMDA) for COVID-19 diagnosis and identification of disease severity biomarkersYing Zhou, Shuofeng Yuan, Kelvin Kai-Wang To, et al.
Investigational New Drugs|May 16, 2019
Zelnorm, an agonist of 5-Hydroxytryptamine 4-receptor, acts as a potential antitumor drug by targeting JAK/STAT3 signalingLei Zhang, Qiaoling Song, Xinxin Zhang, et al.
Annals of the Rheumatic Diseases|September 22, 2019
Vascularised human skin equivalents as a novel in vitro model of skin fibrosis and platform for testing of antifibrotic drugsAlexandru-Emil Matei, Chih-Wei Chen, Lisa Kiesewetter, et al.
Anesthesiology|December 4, 2025
Changes in intraoperative rocuronium dosing following the introduction of sugammadex and association with postoperative respiratory complications: A retrospective cohort studyLuca J Wachtendorf, Lars Kaiser, Elena Ahrens, et al.
Anaesthesia, Critical Care & Pain Medicine|March 9, 2026
Advanced healthcare utilisation after monitored anaesthesia care versus general anaesthesia: A real-world data analysisKara Liebich, Sophia Riesemann, Theresa Tenge, et al.
Pageof 26

Showing results (231-240 of 253) with videos related to

Sort By:
Pageof 26
BMJ Open|August 13, 2025
Patient journey and Quality of Life for Patients with Idiopathic Pulmonary Fibrosis (IPFLife) in China: a sequential exploratory mixed methods research protocolHongling Chu, Yanling Ding, Yunxian Zhou, et al.
Nature Communications|March 28, 2023
Mitochondrial ATP synthase as a direct molecular target of chromium(III) to ameliorate hyperglycaemia stressHaibo Wang, Ligang Hu, Hongyan Li, et al.
BMJ Open Respiratory Research|June 24, 2026
Patient experiences of idiopathic pulmonary fibrosis (IPF) in China: a multicentre qualitative studyBixuan Yan, Ning Liu, Yunxian Zhou, et al.
International Journal of Biological Macromolecules|August 12, 2024
A β-1,3/1,6-glucan enhances anti-tumor effects of PD1 antibody by reprogramming tumor microenvironmentQiaoling Song, Yuting Xu, Minghui Zhang, et al.
Acta Biochimica Et Biophysica Sinica|April 25, 2026
Scaffold compound T4015 attenuates pulmonary fibrosis via suppressing JAK/STAT and NF-κB signalingMinghui Zhang, Hang Xu, Shan Liu, et al.
Chemical Science|April 13, 2022
Multiplex metal-detection based assay (MMDA) for COVID-19 diagnosis and identification of disease severity biomarkersYing Zhou, Shuofeng Yuan, Kelvin Kai-Wang To, et al.
Investigational New Drugs|May 16, 2019
Zelnorm, an agonist of 5-Hydroxytryptamine 4-receptor, acts as a potential antitumor drug by targeting JAK/STAT3 signalingLei Zhang, Qiaoling Song, Xinxin Zhang, et al.
Annals of the Rheumatic Diseases|September 22, 2019
Vascularised human skin equivalents as a novel in vitro model of skin fibrosis and platform for testing of antifibrotic drugsAlexandru-Emil Matei, Chih-Wei Chen, Lisa Kiesewetter, et al.
Anesthesiology|December 4, 2025
Changes in intraoperative rocuronium dosing following the introduction of sugammadex and association with postoperative respiratory complications: A retrospective cohort studyLuca J Wachtendorf, Lars Kaiser, Elena Ahrens, et al.
Anaesthesia, Critical Care & Pain Medicine|March 9, 2026
Advanced healthcare utilisation after monitored anaesthesia care versus general anaesthesia: A real-world data analysisKara Liebich, Sophia Riesemann, Theresa Tenge, et al.
Pageof 26